Literature DB >> 18467733

Bowel perforation after radiotherapy in a patient receiving sorafenib.

Natascha A J B Peters1, Dick J Richel, Joost J C Verhoeff, Lukas J A Stalpers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467733     DOI: 10.1200/JCO.2007.15.8451

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  23 in total

1.  Bowel Perforation After Treatment with Sorafenib: A Case Report and Review of Literature.

Authors:  Shadi Hamdeh; Smrity Upadhyay; Nabin Khanal; Stephen Lanspa
Journal:  J Gastrointest Cancer       Date:  2016-12

Review 2.  Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach.

Authors:  Shankar Siva; Gargi Kothari; Alexander Muacevic; Alexander V Louie; Ben J Slotman; Bin S Teh; Simon S Lo
Journal:  Nat Rev Urol       Date:  2017-06-20       Impact factor: 14.432

3.  Ablation of a site of progression with stereotactic body radiation therapy extends sunitinib treatment from 14 to 22 months.

Authors:  Christopher Straka; D W Nathan Kim; Robert D Timmerman; Ivan Pedrosa; Corbin Jacobs; James Brugarolas
Journal:  J Clin Oncol       Date:  2013-06-24       Impact factor: 44.544

Review 4.  To combine or not combine: the role of radiotherapy and targeted agents in the treatment for renal cell carcinoma.

Authors:  Christian Weiss; Björn Schulze; Annette Ottinger; Claus Rödel
Journal:  World J Urol       Date:  2013-05-08       Impact factor: 4.226

Review 5.  Radiation recall dermatitis induced by sorafenib : A case study and review of the literature.

Authors:  Sonja Stieb; Oliver Riesterer; Cornelia Brüssow; Bernhard Pestalozzi; Matthias Guckenberger; Stefan Weiler
Journal:  Strahlenther Onkol       Date:  2016-02-23       Impact factor: 3.621

Review 6.  Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy.

Authors:  Erqi L Pollom; Lei Deng; Reetesh K Pai; J Martin Brown; Amato Giaccia; Billy W Loo; David B Shultz; Quynh Thu Le; Albert C Koong; Daniel T Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-07-01       Impact factor: 7.038

7.  Sorafenib and radiation therapy for the treatment of advanced hepatocellular carcinoma.

Authors:  Anne M Horgan; Laura A Dawson; Anand Swaminath; Jennifer J Knox
Journal:  J Gastrointest Cancer       Date:  2012-06

8.  Gut commensal derived-valeric acid protects against radiation injuries.

Authors:  Yuan Li; Jiali Dong; Huiwen Xiao; Shuqin Zhang; Bin Wang; Ming Cui; Saijun Fan
Journal:  Gut Microbes       Date:  2020-01-13

9.  Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer.

Authors:  Chul Kim; Jae-Lyun Lee; Yoon Hee Choi; Byung Woog Kang; Min-Hee Ryu; Heung Moon Chang; Tae Won Kim; Yoon-Koo Kang
Journal:  Invest New Drugs       Date:  2010-09-14       Impact factor: 3.850

10.  Use of Systemic Therapy Concurrent With Cranial Radiotherapy for Cerebral Metastases of Solid Tumors.

Authors:  Maikel Verduin; Jaap D Zindler; Hanneke M A Martinussen; Rob L H Jansen; Sander Croes; Lizza E L Hendriks; Danielle B P Eekers; Ann Hoeben
Journal:  Oncologist       Date:  2017-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.